Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone replacement therapy for prostatic inflammation and lower urinary tract symptoms in hypogonadal men
2012-003494-26Phase 4Active
- Sponsor
- Azienda Ospedaliero-Universitaria Careggi
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of testosterone in Hypoandrogenism (TD), benign prostatic hyperplasia (BPH), cardiometabolic risk (CMR) and 2 more, sponsored by Azienda Ospedaliero-Universitaria Careggi. Primary endpoint: Composite symptom response at visit 4. Started Jul 2012; status: active.
02
Drugs
testosterone
03
Conditions
Hypoandrogenism (TD)benign prostatic hyperplasia (BPH)cardiometabolic risk (CMR)prostatitisMicturition disorder
Beyond the preview
Go deeper on 2012-003494-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003494-26.